PTH(1-34) affects osteoprotegerin production in human PDL cells in vitro

Journal of Dental Research

Volumn 84, Issue 7, 2005, Pages 634-638

  Lossdorfer S ^a   Gotz W ^a   Jager A ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Continuous; Intermittent; OPG; PDL cells; PTH

Indexed keywords

ALKALINE PHOSPHATASE; CARRIER PROTEIN; CELL RECEPTOR; GLYCOPROTEIN; MEMBRANE PROTEIN; OSTEOCALCIN; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PARATHYROID HORMONE; PARATHYROID HORMONE (1 34); PARATHYROID HORMONE (1-34); PEPTIDE FRAGMENT; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; TNFRSF11A PROTEIN, HUMAN; TNFRSF11B PROTEIN, HUMAN; TNFSF11 PROTEIN, HUMAN; TUMOR NECROSIS FACTOR RECEPTOR;

ADOLESCENT; ARTICLE; BIOSYNTHESIS; CELL COUNT; CELL CULTURE; CELL DIFFERENTIATION; CHILD; COMPARATIVE STUDY; CYTOLOGY; FEMALE; HUMAN; MALE; METABOLISM; PERIODONTAL LIGAMENT; PHYSIOLOGY; PREMOLAR TOOTH;

ADOLESCENT; ALKALINE PHOSPHATASE; BICUSPID; CARRIER PROTEINS; CELL COUNT; CELL DIFFERENTIATION; CELLS, CULTURED; CHILD; FEMALE; GLYCOPROTEINS; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; OSTEOCALCIN; OSTEOPROTEGERIN; PARATHYROID HORMONE; PEPTIDE FRAGMENTS; PERIODONTAL LIGAMENT; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, TUMOR NECROSIS FACTOR;

EID: 23944486767     PISSN: 00220345     EISSN: None     Source Type: Journal    
DOI: 10.1177/154405910508400710     Document Type: Article

References (25)

1. Barros SP, Silva MA, Somerman MJ, Nociti FH Jr (2003). Parathyroid hormone protects against periodontitis-associated bone loss. J Dent Res 82:791-795.
2. Basdra EK, Komposch G (1997). Osteoblast-like properties of human periodontal ligament cells: an in vitro analysis. Eur J Orthod 19:615-621.
3. Bos MP, van der Meer JM, Feyen JH, Herrmann-Erlee MP (1996). Expression of the parathyroid hormone receptor and correlation with other osteoblastic parameters in fetal rat osteoblasts. Calcif Tissue Int 58:95-100.
4. Bretaudiere JP, Spillman T (1984). Alkaline phosphatases. In: Methods of enzymatic analysis. Bergmeyer HU, editor. Weinheim: Chemica, pp. 75-92.
5. Canalis E, Centrella M, Burch W, McCarthy TL (1989). Insulin-like growth factor I mediates selective anabolic effects of parathyroid hormone in bone cultures. J Clin Invest 83:60-65.
6. Chen HL, Demiralp B, Schneider A, Koh AJ, Silve C, Wang C, et al. (2002). Parathyroid hormone and parathyroid hormone-related protein exert both pro- and anti-apoptotic effects in mesenchymal cells. J Biol Chem 277:19374-19381.
7. Chou AM, Sae-Lim V, Lim T, Schantz J, Teoh S, Chew A, et al. (2002). Culturing and characterization of human periodontal ligament fibroblasts-a preliminary study. Mater Sci Eng 20:77-83.
8. Gori F, Hofbauer LC, Dunstan CR, Speisberg TC, Khosla S, Riggs BL (2000). The expression of osteoprotegerin and RANK ligand and the support of osteoclast formation by stromal-osteoblast lineage cells is developmentally regulated. Endocrinology 141:4768-4776.
9. Halladay DL, Miles RR, Thirunavukkarasu K, Chandrasekhar S, Martin TJ, Onyia JE (2002). Identification of signal transduction pathways and promoter sequences that mediate parathyroid hormone 1-38 inhibition of osteoprotegerin gene expression. J Cell Biochem 84:1-11.
10. Horwood NJ, Elliot J, Martin TJ, Gillespie MT (1998). Osteotropic agents regulate the expression of osteoclast differentiation factor and osteoprotegerin in osteoblastic stromal cells. Endocrinology 139:4743-4746.
11. Huang JC, Sakata T, Pfleger LL, Bencsik M, Halloran BP, Bikle DD, et al. (2004). PTH differentially regulates expression of RANKL and OPG. J Bone Miner Res 19:235-244.
12. Iida-Klein A, Zhou H, Lu SS, Levine LR, Ducayen-Knowles M, Dempster DW, et al. (2002). Anabolic action of parathyroid hormone is skeletal site specific at the tissue and cellular levels in mice. J Bone Miner Res 17:808-816.
13. Ishizuya T, Yokose S, Hori M, Noda T, Suda T, Yoshiki S, et al. (1997). Parathyroid hormone exerts disparate effects on osteoblast differentiation depending on exposure time in rat osteoblastic cells. J Clin Invest 99:2961-2970.
14. Isogai Y, Akatsu T, Ishizuya T, Yamaguchi A, Hori M, Takahashi N, et al. (1996). Parathyroid hormone regulates osteoblast differentiation positively or negatively depending on the differentiation stages. J Bone Miner Res 11:1384-1393.
15. Jilka RL, Weinstein RS, Bellido T, Roberson P, Parfitt AM, Manolagas SC (1999). Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone. J Clin Invest 104:439-446; comment 104:371-373.
16. Kanzaki H, Chiba M, Shimizu Y, Mitani H (2001). Dual regulation of osteoclast differentiation by periodontal ligament cells through RANKL stimulation and OPG inhibition. J Dent Res 80:887-891.
17. Kanzawa M, Sugimoto T, Kanatani M, Chihara K (2000). Involvement of osteoprotegerin/osteoclastogenesis inhibitory factor in the stimulation of osteoclast formation by parathyroid hormone in mouse bone cells. Eur J Endocrinol 142:661-664.
18. Kondo H, Ohyama T, Ohya K, Kasugai S (1997). Temporal changes of niRNA expression of matrix proteins and parathyroid hormone and parathyroid hormone-related protein (PTH/PTHrP) receptor in bone development. J Bone Miner Res 12:2089-2097.
19. Lee SK, Lorenzo JA (1999). Parathyroid hormone stimulates TRANCE and inhibits osteoprotegerin messenger ribonucleic acid expression in murine bone marrow cultures: correlation with osteoclast-like cell formation. Endocrinology 140:3552-3561.
20. Ma YL, Cain R, Halladay D, Yang X, Zeng Q, Miles RR, et al. (2001). Catabolic effects of continuous human PTH (1-38) in vivo is associated with sustained stimulation of RANKL and inhibition of osteoprotegerin and gene-associated bone formation. Endocrinology 142:4047-4054.
21. McCauley LK, Koh AJ, Beecher CA, Cui Y, Rosol TJ, Franceschi RT (1996). PTH/PTHrP receptor is temporally regulated during osteoblast differentiation and is associated with collagen synthesis. J Cell Biochem 61:638-647.
22. Morley P, Whitfield JF, Willick GE (2001). Parathyroid hormone: an anabolic treatment for osteoporosis. Curr Pharm Des 7:671-687.
23. Nakajima A, Shimoji N, Shiomi K, Shimizu S, Moriya H, Einhorn TA, et al. (2002). Mechanisms for the enhancement of fracture healing in rats treated with intermittent low-dose human parathyroid hormone (1-34). J Bone Miner Res 17:2038-2047.
24. Schiller PC, D'Ippolito G, Roos BA, Howard GA (1999). Anabolic or catabolic responses of MC3T3-E1 osteoblastic cells to parathyroid hormone depend on time and duration of treatment. J Bone Miner Res 14:1504-1512.
25. Skripitz R, Aspenberg P (2001). Early effect of parathyroid hormone (1-34) on implant fixation. Clin Orthop Relat Res 392:427-432.